The innovative immunoglobulin, designated 2H7, demonstrates significant binding against simultaneous CD20 antigens found in monkey and patient species. The discovery presents value for future investigation into disease https://www.targetmol.com/compound/anti-monkey-human-cd20-antibody-2h7